Related Experiment Video
Updated: Jul 5, 2026

06:47
Experimental Analysis of Apoptotic Thymocyte Engulfment by Macrophages
Published on: May 24, 2019
Assay for macrophage-mediated anti-tumor cytotoxicity
1National Cancer Institute, Frederick, Maryland, USA.
Current Protocols in Immunology
|April 25, 2008
Summary
This study details a method to assess mouse macrophage ability to destroy tumor cells in vitro. The assay measures the release of radioactive indium (111In) from damaged tumor cells, indicating macrophage-mediated tumor cell lysis.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Macrophages play a crucial role in the immune response against tumors.
- Quantifying macrophage-mediated tumor cell lysis is essential for understanding anti-tumor immunity.
- Existing methods may require refinement for accurate in vitro assessment.
Purpose of the Study:
- To describe a reliable in vitro assay for determining the tumoricidal capacity of mouse macrophages.
- To provide a detailed protocol for assessing macrophage-mediated tumor cell lysis.
- To enable researchers to evaluate the efficacy of macrophage activation strategies.
Main Methods:
- A three-stage assay involving macrophage culture with activating reagents.
- Extensive washing of macrophages to remove residual activating agents.
- Incubation with indium-111 (111In)-labeled tumor cells and measurement of released radioactivity to quantify lysis.
Main Results:
- The protocol successfully quantifies macrophage-mediated lysis of tumor cells in vitro.
- The release of 111In from labeled tumor cells directly correlates with cytolytic activity.
- A support protocol for radiolabeling tumor cells with 111In-oxine is also provided.
Conclusions:
- This assay provides a robust method for evaluating mouse macrophage anti-tumor activity.
- The described procedure is valuable for immunological and cancer research.
- Accurate measurement of macrophage-mediated cytotoxicity can inform therapeutic strategies.
